BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nayman AH, Siginc H, Zemheri E, Yencilek F, Yildirim A, Telci D. Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo. J Cancer 2019;10:1466-78. [PMID: 31031856 DOI: 10.7150/jca.29192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Dong C, Dang D, Zhao X, Wang Y, Wang Z, Zhang C. Integrative Characterization of the Role of IL27 In Melanoma Using Bioinformatics Analysis. Front Immunol 2021;12:713001. [PMID: 34733272 DOI: 10.3389/fimmu.2021.713001] [Reference Citation Analysis]
2 Cheng G, Yu Y, Wang L, Pan Q. Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma. Aging (Albany NY) 2020;12:7448-64. [PMID: 32315986 DOI: 10.18632/aging.103091] [Reference Citation Analysis]
3 Li S, Sheng J, Liu Z, Fan Y, Zhang C, Lv T, Hu S, Jin J, Yu W, Song Y. Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel-sensitive and docetaxel-resistant castration-resistant prostate cancer cells. J Cell Mol Med 2021;25:2436-49. [PMID: 33507584 DOI: 10.1111/jcmm.16155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Saoudaoui S, Bernard M, Cardin GB, Malaquin N, Christopoulos A, Rodier F. mTOR as a senescence manipulation target: A forked road. Adv Cancer Res 2021;150:335-63. [PMID: 33858600 DOI: 10.1016/bs.acr.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Erkan H, Telci D, Dilek O. Design of Fluorescent Probes for Bioorthogonal Labeling of Carbonylation in Live Cells. Sci Rep 2020;10:7668. [PMID: 32376913 DOI: 10.1038/s41598-020-64790-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Poma P, Labbozzetta M, Zito P, Alduina R, Ramarosandratana AV, Bruno M, Rosselli S, Sajeva M, Notarbartolo M. Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models. Molecules 2019;24:E2871. [PMID: 31394879 DOI: 10.3390/molecules24162871] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
7 Chen T, Shao S, Li W, Liu Y, Cao Y. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines. Artif Cells Nanomed Biotechnol 2019;47:3638-48. [PMID: 31456425 DOI: 10.1080/21691401.2019.1657873] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
8 Rayego-Mateos S, Marquez-Expósito L, Rodrigues-Diez R, Sanz AB, Guiteras R, Doladé N, Rubio-Soto I, Manonelles A, Codina S, Ortiz A, Cruzado JM, Ruiz-Ortega M, Sola A. Molecular Mechanisms of Kidney Injury and Repair. Int J Mol Sci 2022;23:1542. [PMID: 35163470 DOI: 10.3390/ijms23031542] [Reference Citation Analysis]
9 Li MX, Li MY, Lei JX, Wu YZ, Li ZH, Chen LM, Zhou CL, Su JY, Huang GX, Huang XQ, Zheng XB. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier. Phytomedicine 2022;100:154052. [PMID: 35344714 DOI: 10.1016/j.phymed.2022.154052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bolat ZB, Nezir AE, Devrim B, Zemheri E, Gulyuz S, Ozkose UU, Yilmaz O, Bozkir A, Telci D, Sahin F. Delivery of doxorubicin loaded P18 conjugated-poly(2-ethyl-oxazoline)-DOPE nanoliposomes for targeted therapy of breast cancer. Toxicol Appl Pharmacol 2021;428:115671. [PMID: 34391753 DOI: 10.1016/j.taap.2021.115671] [Reference Citation Analysis]
11 Zhang C, Dang D, Liu C, Wang Y, Cong X. Identification of tumor mutation burden-related hub genes and the underlying mechanism in melanoma. J Cancer 2021;12:2440-9. [PMID: 33758620 DOI: 10.7150/jca.53697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]